New York State Common Retirement Fund
IMRX icon

New York State Common Retirement Fund’s Immuneering IMRX Stock Holding History

New York State Common Retirement Fund’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.4K Buy
+12,100
New +$61.2K ﹤0.01% 2919
2024
Q3 		– Sell
-209
Closed -$268 – 3268
2024
Q2 		$268 Sell
209
-9,460
-98% -$15.6K ﹤0.01% 3367
2024
Q1 		$27.9K Buy
9,669
+574
+6% +$3.22K ﹤0.01% 3108
2023
Q4 		$66.8K Sell
9,095
-41
-0.4% -$273 ﹤0.01% 2906
2023
Q3 		$70.2K Buy
9,136
+236
+3% +$2.17K ﹤0.01% 2896
2023
Q2 		$90.2K Buy
+8,900
New +$85.6K ﹤0.01% 2942
2022
Q3 		– Sell
-165
Closed -$1K – 3360
2022
Q2 		$1K Sell
165
-4,472
-96% -$23.9K ﹤0.01% 3363
2022
Q1 		$30K Hold
4,637
– – ﹤0.01% 3252
2021
Q4 		$75K Buy
4,637
+2,937
+173% +$71.5K ﹤0.01% 3146
2021
Q3 		$45K Buy
+1,700
New +$45.7K ﹤0.01% 3257

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

New York State Common Retirement Fund's IMRX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Immuneering (IMRX) in Q2 2026: 12,100 shares worth $60.4K. The stake represents ﹤0.01% of the portfolio and ranks #2919 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in IMRX as recently as Q2 2024.

New York State Common Retirement Fund first reported a position in IMRX in Q3 2021 and has held it in 10 quarters since. The position peaked at $90.2K in Q2 2023. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • New York State Common Retirement Fund held 12,100 shares of Immuneering worth $60.4K as of Q2 2026.
  • Immuneering was a new New York State Common Retirement Fund position in Q2 2026.
  • Immuneering made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2919 holding.
  • New York State Common Retirement Fund first reported a position in Immuneering in Q3 2021 and has held it in 10 quarters since.
  • New York State Common Retirement Fund's Immuneering position peaked at $90.2K in Q2 2023.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.